The distinction matters, because the headline nausea percentages sound far more alarming than the discontinuation data warrants
Without sufficient protein, patients risk losing substantial muscle mass alongside fat tissue, which can reduce metabolic rate, impair physical function, and compromise long-term weight maintenance
The regulatory status should be verified at the time of reading, as this may change as trials progress
Wegovy and Mounjaro are currently the safest and most effective approved options
Multiple studies have shown reductions in inflammatory markers among people taking GLP-1 agonists, and patients frequently report improvements in inflammation-related conditions
Key proposed mechanisms include: GLP-1 receptors on adipose-derived stem cells (ADSCs)